Table 1 Eligibility criteria

  1.

Be 18 years of age or older

  2.

Have a confirmed diagnosis of COVID-19 with a PCR test at least 12 weeks prior OR a confirmed rapid antigen test at least 12 weeks prior OR meet Ottawa Public Health guidance for a suspected COVID-19 case (Table 2)

  3.

Have at least one ongoing symptom consistent with Long COVID as measured by the WHO Post COVID Case Report Form (CRF)

  4.

Have a minimum WHO Disability Assessment Scale (WHODAS) self-report (36 item) sum score of 15

  5.

Be willing to use email for study activities

  6.

Be able and willing to use an electronic platform, either on smartphone or computer web browser, for the duration of the trial

  7.

Be able to read and understand English or French.

  8.

Be willing and able to provide informed consent.

  1.

Have any significant functional impairment (for example, advanced dementia, heart or lung disease) as judged by the assessing clinician

  2.

Participate in another Long COVID trial where treatment is required in the protocol (pharmacological or behavioral). Observational studies will be allowed.

  3.

Have symptoms consistent with Long COVID that are better explained by an alternative diagnosis